BIOLOGICAL · Unmapped registry intervention
sargramostim
Find medicine records ·
Find other trials using this name
Clinical trial
Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
NCT00514215
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
flow cytometry
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
immunoenzyme technique
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
biopsy
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
cryosurgery
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedCryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Kidney Cancerverified · MONDO: kidney cancer
Lung Cancerverified · MONDO: lung cancer
Interventions
Sponsors & collaborators
Barbara Ann Karmanos Cancer Institutelead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00514215 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.